Source:http://linkedlifedata.com/resource/pubmed/id/19035845
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-11-27
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1540-658X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
611-20
|
pubmed:meshHeading |
pubmed-meshheading:19035845-Biotechnology,
pubmed-meshheading:19035845-Career Choice,
pubmed-meshheading:19035845-Chemistry, Pharmaceutical,
pubmed-meshheading:19035845-Drug Evaluation, Preclinical,
pubmed-meshheading:19035845-Great Britain,
pubmed-meshheading:19035845-Industry,
pubmed-meshheading:19035845-Molecular Biology,
pubmed-meshheading:19035845-National Institutes of Health (U.S.),
pubmed-meshheading:19035845-United States
|
pubmed:year |
2008
|
pubmed:articleTitle |
An interview with Andrew D. Napper, Ph.D. Interview.
|
pubmed:publicationType |
Interview
|